“The FDA recommends that the Company’s proposed primary symptom-based endpoints should cover the evaluation of time to sustained recovery assessed over an appropriate duration, evidence of subjects experiencing resolution of COVID-19 related symptoms and the element of sustained symptom resolution”
Why wouldn’t this have already been included with their proposed symptom relief endpoints? This is common sense.
Market Data 
Markets 
AI
